Results 11 to 20 of about 4,593,278 (410)
Comparison of Standard Neoadjuvant Therapy and Total Neoadjuvant Therapy in Terms of Effectiveness in Patients Diagnosed with Locally Advanced Rectal Cancer. [PDF]
Background/Objectives: The study aimed to compare the treatment effectiveness of patients with locally advanced rectal cancer undergoing standard neoadjuvant therapy or total neoadjuvant therapy.
Bayramgil A+11 more
europepmc +2 more sources
Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition) [PDF]
Neoadjuvant therapy has become one of the standard treatments in early breast cancer. In 2019, China breast cancer neoadjuvant therapy expert group discussed and expounded the purpose, indication, evaluation criteria, surgical operation principles and ...
Expert group of expert consensus on neoadjuvant treatment of breast cancer in China ( edition)
doaj +1 more source
Neoadjuvant therapy in patients with locally advanced colon cancer [PDF]
It is still unclear about neoadjuvant therapy in patients with locally advanced colon cancer (LACC). This review summarized neoadjuvant chemotherapy, neoadjuvant chemotherapy combined with targeted therapy and combined radio-chemotherapy for the patients
XU Zifeng, ZONG Yaping, LU Aiguo
doaj +1 more source
Study on pathological factors affecting the sensitivity of neoadjuvant therapy in hypopharyngeal cancer. [PDF]
Objective Hypopharyngeal squamous cell carcinoma (HSCC) is a highly malignant tumor type in the head and neck region. In recent years, neoadjuvant therapy has significantly improved the laryngeal preservation rate among patients.
Yin G+5 more
europepmc +2 more sources
Neoadjuvant therapy for gallbladder cancer: current status and challenge [PDF]
Gallbladder cancer is one of highly malignant digestive system tumors with insidious symptoms, rapid progression, and poor prognosis. Although radical resective surgery is the only possible curative way for gallbladder cancer, most patients have lost the
XING Ying, CHENG Shi
doaj +1 more source
Immune checkpoint inhibitors and antiangiogenic agents have shown some activity in patients with late-stage gastric cancer. Here the authors report the results of a phase II trial of neoadjuvant anti-PD1 (camrelizumab), antiangiogenic agent (apatinib ...
Song Li+22 more
semanticscholar +1 more source
Association between pathologic response and survival after neoadjuvant therapy in lung cancer
Analysis of the phase 3 CheckMate 816 trial shows that the depth of pathologic response as assessed by percent residual viable tumor is correlated with event-free survival following neoadjuvant immunotherapy plus chemotherapy, supporting pathologic ...
J. Deutsch+23 more
semanticscholar +1 more source
Total neoadjuvant therapy for rectal cancer: a guide for surgeons
Summary The modern management of rectal cancers continues to evolve. With the release of data from new landmark randomized controlled trials (RAPIDO, PRODIGE-23), total neoadjuvant therapy (TNT) has moved to the forefront of locally advanced rectal ...
Garrett Johnson+5 more
semanticscholar +1 more source
Background: The efficacy of neoadjuvant therapy for rectal cancer has not been assessed. Objective: To evaluate proportional changes in peripheral blood immune cells in rectal cancer patients after neoadjuvant therapy and assess the relationship between ...
Liu Maoxi, Liu Haiyi
doaj +1 more source